Remove 2007 Remove COVID-19 Remove FDA Remove Licensing
article thumbnail

Analysis: Seeking Balance in the Hyperactive Mental Health Tech Market

HIT Consultant

While Covid-19 initially exacerbated difficulties in access, the swift public emergency declarations that led to the easing of regulations proved a catalyzer for remote models that had previously struggled to gain adoption. With increased competition, companies in the space are eyeing FDA approval as a key point of differentiation.